https://pastelink.net/4e51sdyc has been shown to lead to greater weight reduction than different glucagon-like peptide analogues. You should not use liraglutide if you have a quantity of endocrine neoplasia sort 2 , a private or household historical past of medullary thyroid cancer. Food and Drug Administration in 2014, and by the European Medicines Agency in 2015, for adults with a physique mass index of 30 or greater or a BMI of 27 or larger who've a minimum of one weight-related condition. Liraglutide leads to insulin launch in pancreatic beta cells in the presence of elevated blood glucose. This insulin secretion subsides as glucose concentrations decrease and method euglycemia . It additionally decreases glucagon secretion in a glucose-dependent manner and delays gastric emptying.<div style="text-align:center"> <iframe width="562" height="315" src="https://www.youtube.com/embed/2fpT_qTRbfc" frameborder="0" alt="liraglutid kaufen" allowfullscreen></iframe></div>Use in being pregnant and breastfeeding is of unclear safety. Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also referred to as incretin mimetics. It works by increasing insulin release from the pancreas and reduces extreme glucagon launch. Liraglutide, bought underneath the model names Victoza and Saxenda amongst others, is an anti-diabetic treatment used to treat kind 2 diabetes, and persistent obesity. It is a second-line remedy for diabetes following first-line therapy with metformin.Food and Drug Administration to instantly remove liraglutide from the market because they concluded that dangers of thyroid cancer and pancreatitis outweigh any documented advantages. At exposures eight instances greater than those used in humans, liraglutide triggered a statistically significant enhance in thyroid tumors in rats. In medical trials, the speed of thyroid tumors in sufferers handled with liraglutide was 1.3 per 1000 patient years compared to 1.0 per one thousand patients as compared groups. The sole individual within the comparator group and 4 of the five individuals within the liraglutide group had serum markers suggestive of pre-existing illness at baseline. Other medicine could affect liraglutide, including prescription and over-the-counter medicines, vitamins, and natural products. Tell your physician about all of your present medicines and any medication you begin or stop utilizing.<h2>Liraglutid Kaufen: Informationen Und Tipps Zu Produkten Und Preisen</h2>Its effects on long-term health outcomes like heart disease and life expectancy are unclear. In patients with high cardiovascular risk, liraglutide has been shown to reduce the chance for first prevalence of demise from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. ADA tips currently think about liraglutide a first line pharmacologic remedy for sort 2 diabetes , specifically for sufferers with atherosclerotic cardiovascular disease or weight problems.<img class="aligncenter" style="display: block;margin-left:auto;margin-right:auto;" src="data:image/jpeg;base64,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" width="305px" alt="children">It reduces meal-related hyperglycemia by increasing insulin secretion when required by increasing glucose ranges, delaying gastric emptying, and suppressing prandial glucagon secretion. Remember, maintain this and all different medicines out of the reach of kids, never share your medicines with others, and use this treatment only for the indication prescribed. Analysts at Citi Research concur, assuming that the drug will reach less than 0.5 percent of the 107 million folks in the United States categorized as obese, and a every day price of $30 over 6 to 12 months' use. The firm estimates that it has spent about $1 billion over ten years to take Saxenda from research to marketing. The best way to lookup drug information, determine drugs, check interactions and set up your own personal medication information.<h3>Muss Ich Dennoch Sport Betreiben Und Eine Diät Einhalten, Wenn Ich Saxenda Anwende?</h3>Unlike endogenous GLP-1, liraglutide is stable against metabolic degradation by peptidases, with a plasma half-life of 13 hours. https://anotepad.com/notes/w8cfgppx is injected under the skin at any time of the day, with or with no meal. A healthcare provider may train you the way to properly use the medication by your self. Read and thoroughly comply with any Instructions for Use offered with your medication. Ask your physician or pharmacist should you do not understand all instructions. In 2012, the non-profit shopper advocacy group Public Citizen petitioned the U.S.The Saxenda model of liraglutide is used together with food regimen and train to help people shed weight when they have sure health situations. https://te.legra.ph/Ozempic-Makes-Use-Of-Dose-Side-Effects-Directions-09-19 is to be used in adults with a body mass index of 30 or higher, and for kids no much less than 12 years old who weigh greater than 132 kilos . Liraglutide may also be used together with diet and train for continual weight administration in adults.Never share an injection pen, cartridge, or syringe with another particular person, even if the needle has been changed. Sharing these devices can enable infections or disease to pass from one individual to a different. Also watch for indicators of excessive blood sugar such as increased thirst or urination.<ul> <li>Analysts at Citi Research concur, assuming that the drug will reach lower than 0.5 % of the 107 million folks within the United States categorised as overweight, and a day by day value of $30 over 6 to 12 months' use.</li> <li>Use in being pregnant and breastfeeding is of unclear security.</li> <li>Be sure your family or close pals know the method to give you this injection in an emergency.</li> <li>It additionally decreases glucagon secretion in a glucose-dependent manner and delays gastric emptying.</li> <li>Common unwanted side effects include low blood sugar, nausea, dizziness, belly pain, and pain on the web site of injection.</li></ul>Follow all instructions in your prescription label and skim all medicine guides or instruction sheets. In 2010, Novo Nordisk breached the ABPI's code of conduct by failing to offer details about unwanted effects, and by selling it previous to being granted market authorization. Liraglutide is marketed under the brand name Victoza in the united states, U.K. UAE, Kuwait, India, Iran, Canada, Europe, Japan and Philippines. It has been launched in Germany, Italy, Denmark, the Netherlands, Sweden, Japan, Canada, the United States, France, Indonesia, Malaysia and Singapore. Liraglutide can also be known to be marketed as Saxenda in Norway, Australia, Indonesia, Iran, Israel, Canada, Brazil, Switzerland, The United Kingdom, Ireland, Poland and the united states Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) agonist, derived from human GLP-1-(7-37), a much less common type of endogenous GLP-1.Do not use Saxenda together with different weight reduction merchandise, diet pills, or urge for food suppressants. A personal or household history of medullary thyroid carcinoma . Victoza can be used to help cut back the chance of serious heart issues such as coronary heart attack or stroke in adults who have kind 2 diabetes and heart illness.

トップ   編集 凍結 差分 バックアップ 添付 複製 名前変更 リロード   新規 一覧 単語検索 最終更新   ヘルプ   最終更新のRSS
Last-modified: 2023-09-19 (火) 14:17:30 (231d)